Focusing on a French setting where managers
can choose to capitalize R&D expenditures under certain circumstances,
we find that, after controlling for industry effects, firms
that capitalize R&D expenditures spend less on R&D, have more
volatile R&D efforts, and are smaller and more leveraged than firms
that expense R&D expenditures.